The landscape of dementia analysis has progressed considerably with the advent of complex biomarkers, such as amyloid PET scans, tau imaging, and blood-dependent tests that will detect Alzheimer's pathology decades prior to indicators arise. While these technological improvements characterize remarkable progress in knowledge neurodegenerative healt